---
figid: PMC3420350__JBB2012-691369.001
figlink: /pmc/articles/PMC3420350/figure/fig1/
number: F1
caption: Insulin resistance in chronic kidney disease. Renal failure and adipose tissue
  lead to systemic inflammation and increased plasma levels of adipokines. TNF-α activates
  adipose tissue lipolysis, which generates free-fatty acids (FFAs). On muscle cells,
  FFAs activate transcription factors, such as peroxisome proliferator-activated receptor
  (PPAR), and generate messengers including diacylglycerol (DAG) and long-chain acyl-CoA
  (LCA-CoA), which will lead to protein kinase C (PKC) activation and dephosphorylation
  of insulin receptor substrate (IRS)-1/2. On muscle cells, TNF-α activates a series
  of kinases including IKK-β, c-Jun NH2-terminal kinase (JNK), extracellular signal-regulated
  kinase (ERK), protein kinase C (PKC), Akt (PKB), mammalian target of rapamycin (mTOR),
  and glycogen synthase kinase 3 (GSK3) responsible for phosphorylation of insulin
  receptor (InsR) and IRS-1 on serine/threonine residues. Inhibition of IRS-1 function
  will block Akt leading to cytosol glucose transporter 4 (GLUT4) sequestration. Fetuin-A
  could also inhibit IRS and induce low-grade inflammation. IL-6 is responsible for
  the induction of different suppressors of cytokine signaling (SOCS) proteins through
  the Janus kinase/signal transducer and activator of transcription (Jak/STAT)-signaling
  pathway. SOCS will inhibit IRS-1/2 and protein kinase A. Endoplasmic reticulum stress
  seems to be another factor linking inflammation and insulin resistance at the molecular
  level. Red line illustrates the mechanism of CKD-related factors in IR.
pmcid: PMC3420350
papertitle: Insulin Resistance in Patients with Chronic Kidney Disease.
reftext: Min-Tser Liao, et al. J Biomed Biotechnol. 2012;2012:691369.
pmc_ranked_result_index: '119586'
pathway_score: 0.8883
filename: JBB2012-691369.001.jpg
figtitle: Insulin resistance in chronic kidney disease
year: '2012'
organisms: Homo sapiens
ndex: 53d194c1-df16-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3420350__JBB2012-691369.001.html
  '@type': Dataset
  description: Insulin resistance in chronic kidney disease. Renal failure and adipose
    tissue lead to systemic inflammation and increased plasma levels of adipokines.
    TNF-α activates adipose tissue lipolysis, which generates free-fatty acids (FFAs).
    On muscle cells, FFAs activate transcription factors, such as peroxisome proliferator-activated
    receptor (PPAR), and generate messengers including diacylglycerol (DAG) and long-chain
    acyl-CoA (LCA-CoA), which will lead to protein kinase C (PKC) activation and dephosphorylation
    of insulin receptor substrate (IRS)-1/2. On muscle cells, TNF-α activates a series
    of kinases including IKK-β, c-Jun NH2-terminal kinase (JNK), extracellular signal-regulated
    kinase (ERK), protein kinase C (PKC), Akt (PKB), mammalian target of rapamycin
    (mTOR), and glycogen synthase kinase 3 (GSK3) responsible for phosphorylation
    of insulin receptor (InsR) and IRS-1 on serine/threonine residues. Inhibition
    of IRS-1 function will block Akt leading to cytosol glucose transporter 4 (GLUT4)
    sequestration. Fetuin-A could also inhibit IRS and induce low-grade inflammation.
    IL-6 is responsible for the induction of different suppressors of cytokine signaling
    (SOCS) proteins through the Janus kinase/signal transducer and activator of transcription
    (Jak/STAT)-signaling pathway. SOCS will inhibit IRS-1/2 and protein kinase A.
    Endoplasmic reticulum stress seems to be another factor linking inflammation and
    insulin resistance at the molecular level. Red line illustrates the mechanism
    of CKD-related factors in IR.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - STAT6
  - GSK3B
  - IKBKB
  - MAPK1
  - SLC2A4
  - STAT5B
  - AKT1
  - JAK2
  - STAT4
  - SOCS3
  - KRAS
  - MTOR
  - GSK3A
  - NRAS
  - AKT2
  - JAK1
  - MAPK3
  - PRKCZ
  - AKT3
  - ADIPOQ
  - PRKCQ
  - STAT5A
  - STAT1
  - HRAS
  - JAK3
  - TNF
  - IRS2
  - PRKCE
  - PIK3CB
  - PIK3R5
  - PRKCD
  - IRS4
  - IRS1
  - PRKCH
  - PRKCI
  - PRKD3
  - PRKCA
  - PIK3R6
  - PIK3R3
  - STAT3
  - MAPK10
  - STAT2
  - MAPK8
  - PRKCG
  - MAP2K1
  - PIK3R4
  - PIK3CG
  - PRKCB
  - MAP2K2
  - PIK3CA
  - MAPK9
  - PIK3CD
  - TYK2
  - IL6
  - serine
  - Cancer
  - Diabetes mellitus
genes:
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: IKK-B,
  symbol: IKK-beta
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: GLUT4
  symbol: GLUT4
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A4
  entrez: '6517'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: PKC,Akt/PKB,MTOR
  symbol: PKB
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: SOCS3
  symbol: SOCS3
  source: hgnc_symbol
  hgnc_symbol: SOCS3
  entrez: '9021'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PKC,Akt/PKB,MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PKC,Akt/PKB,MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PKC,Akt/PKB,MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PKC,Akt/PKB,MTOR
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC,Akt/PKB,MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Adiponectin
  symbol: adiponectin
  source: hgnc_alias_symbol
  hgnc_symbol: ADIPOQ
  entrez: '9370'
- word: PKC,Akt/PKB,MTOR
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: TNF-a
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: PKC,Akt/PKB,MTOR
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PKC,Akt/PKB,MTOR
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS4
  entrez: '8471'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: PKC,Akt/PKB,MTOR
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC,Akt/PKB,MTOR
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC,Akt/PKB,MTOR
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC,Akt/PKB,MTOR
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: IKK-B,JNK,ERK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: IKK-B,JNK,ERK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PKC,Akt/PKB,MTOR
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PKC,Akt/PKB,MTOR
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: IKK-B,JNK,ERK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
chemicals:
- word: serine
  source: MESH
  identifier: D012694
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Diabetes mellitus
  source: ''
  identifier: ''
figid_alias: PMC3420350__F1
redirect_from: /figures/PMC3420350__F1
figtype: Figure
---
